At the time of writing, Milestone Pharmaceuticals Inc [MIST] stock is trading at $2.01, saw in change for the day. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MIST shares have gain 4.15% over the last week, with a monthly amount drifted -3.37%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Milestone Pharmaceuticals Inc [NASDAQ: MIST] stock has seen the most recent analyst activity on December 15, 2025, when TD Cowen upgraded its rating to a Buy but kept the price target unchanged to $8 for it. Previously, Wells Fargo started tracking the stock with Overweight rating on September 11, 2025, and set its price target to $4. Rodman & Renshaw started tracking the stock assigning a Buy rating and suggested a price target of $9 on August 22, 2024. Jefferies downgraded its rating to a Hold and reduced its price target to $4 on June 20, 2023. Piper Sandler upgraded its rating to Overweight for this stock on April 22, 2022, and upped its price target to $10. In a note dated March 05, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $20 on this stock.
For the past year, the stock price of Milestone Pharmaceuticals Inc fluctuated between $0.63 and $3.06. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $2.01 at the most recent close of the market. An investor can expect a potential return of 298.01% based on the average MIST price forecast.
Analyzing the MIST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -23.73 and Total Capital is -0.74. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Milestone Pharmaceuticals Inc [NASDAQ:MIST] has a current ratio of 8.24. Further, the Quick Ratio stands at 8.24, while the Cash Ratio is 4.44.
Transactions by insiders
Recent insider trading involved Oliveto Joseph, President and CEO, that happened on Jan 08 ’26 when 43000.0 shares were sold. President and CEO, Oliveto Joseph completed a deal on Jan 07 ’26 to sell 500.0 shares. Meanwhile, Director JOSEPH OLIVETO bought 79500.0 shares on Jan 08 ’26.
